7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiac Enzyme Levels
Cardiac enzymes are essential indicators in the assessment of heart health, providing valuable insights into cardiac conditions. These enzymes, including myoglobin, creatine kinase-MB (CK-MB), and aspartate aminotransferase (AST), serve as sensitive markers for myocardial damage. Elevated levels of these enzymes in the bloodstream can signal various cardiac issues, such as myocardial infarction or angina. Among them, CK-MB is particularly specific to heart muscle, aiding in the accurate diagnosis of heart-related disorders. The measurement and interpretation of cardiac enzyme levels empower healthcare professionals to make informed decisions, facilitating early detection and intervention in cardiac emergencies. Understanding the nuances of different cardiac enzymes enhances the precision of cardiovascular diagnostics, contributing to more effective patient care.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya